unassigned: Bazi Bushen capsule (BZBS) has anti-ageing properties and is effective in enhancing memory.
unassigned: To find evidence supporting the mechanisms and biomarkers by which BZBS functions.
unassigned: Male C57BL/6J mice were randomly divided into five groups: normal, ageing, β-nicotinamide mononucleotide capsule (NMN), BZBS low-dose (LD-BZ) and BZBS high-dose (HD-BZ). The last four groups were subcutaneously injected with d-galactose (d-gal, 100?mg/kg/d) to induce the ageing process. At the same time, the LD-BZ, HD-BZ and NMN groups were intragastrically injected with BZBS (1 and 2?g/kg/d) and NMN (100?mg/kg/d) for treatment, respectively. After 60?days, the changes in overall ageing status, b... More
unassigned: Bazi Bushen capsule (BZBS) has anti-ageing properties and is effective in enhancing memory.
unassigned: To find evidence supporting the mechanisms and biomarkers by which BZBS functions.
unassigned: Male C57BL/6J mice were randomly divided into five groups: normal, ageing, β-nicotinamide mononucleotide capsule (NMN), BZBS low-dose (LD-BZ) and BZBS high-dose (HD-BZ). The last four groups were subcutaneously injected with d-galactose (d-gal, 100?mg/kg/d) to induce the ageing process. At the same time, the LD-BZ, HD-BZ and NMN groups were intragastrically injected with BZBS (1 and 2?g/kg/d) and NMN (100?mg/kg/d) for treatment, respectively. After 60?days, the changes in overall ageing status, brain neuron morphology, expression of p16, proliferating cell nuclear antigen (PCNA), ionized calcium-binding adapter molecule 1 (Iba1), postsynaptic density protein 95 (PSD95), CD11b, Arg1, CD206, Trem2, Ym1 and Fizz1, and the senescence-associated secretory phenotype (SASP) factors were observed.
unassigned: Compared with the mice in the ageing group, the HD-BZ mice exhibited obvious improvements in strength, endurance, motor coordination, cognitive function and neuron injury. The results showed a decrease in p16, Iba1 and the upregulation of PCNA, PSD95 among brain proteins. The brain mRNA exhibited downregulation of Iba1 (?0.001), CD11b (?0.001), and upregulation of Arg1 (?0.01), CD206 (?0.05), Trem2 (?0.001), Ym1 (?0.01), Fizz1 (?0.05) and PSD95 (?0.01), as well as improvement of SASP factors.
unassigned: BZBS improves cognitive deficits via inhibition of cellular senescence and microglia activation. This study provides experimental evidence for the wide application of BZBS in clinical practice for cognitive deficits.